Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 109

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 109
---
 (which include directors, employees, contractors and consultants) under a free grant (receiving an allocation of shares,
options or rights for no consideration) or salary contribution agreement. An option confers a right to acquire a share during the exercise
period, subject to the satisfaction of any vesting conditions, the payment of the exercise price for the option (including through a cashless
exercise facility) set out in the offer, and otherwise in the manner required by the Board and specified by the offer. A performance right
confers an entitlement to be issued, transferred or allocated one share after the vesting date, subject to any disposal restrictions,
the satisfaction of the vesting conditions, and any other requirements contained in the offer. A share appreciation right confers an entitlement
to be issued, transferred or allocated the number of shares calculated under the terms of the Omnibus Incentive Plan after the vesting
date, subject to any disposal restrictions, the satisfaction of the vesting conditions and any other requirement contained in the offer.
The Board may decide, in its absolute discretion to substitute the issue, transfer of allocation of these securities for the payment of
a cash amount.

The Board may amend the
Omnibus Incentive Plan in any manner it decides subject to Rule 17.2 of the Omnibus Incentive Plan, which prohibits the Board from
making any amendment to the Omnibus Incentive Plan that would have the effect of materially adversely affecting or prejudicing the
rights of any participant holding awards. The Omnibus Incentive Plan may be terminated or suspended at any time by the Board and
that termination or suspension will not have any effect on or prejudice the rights of any participant holding awards at that time.
The Board must not grant shares, options, performance rights and share appreciation rights under the Omnibus Incentive Plan if the
number of shares that could be exercised in aggregate would exceed 5% of the total number of the Company’s ordinary shares on
issue at the date of the grant.

Ordinary Share holdings

As at June 30, 2025, the number of ordinary shares
held by our directors and officers were as follows:

  Ordinary shares                                                                         
  Riccardo Canevari            9,653,584      7,776,402      3,750,000        21,179,986  
  Paul Hopper                 94,221,428      -              53,500,000      147,721,428